← Back to all trials
Completed
NCT06310785
Esketamine Anesthesia in Thoracic Surgery
Conditions: General Anesthesia, Thoracic Surgery
Sex: All
Ages: 18 Years – 70 Years
Healthy volunteers: No
Phase: NA
Enrollment: 84
Sponsor: Hui Xu
Location: Tongji Hospital Wuhan Hubei
Summary
Patients in the esketamine group was induced with esketamine 0.5 mg/kg, propofol 2 mg/kg, and rocuronium 0.9 mg/kg. Anesthesia is maintained with propofol 5 mg/kg/h and esketamine 0.5 mg/kg/h. Patients in the opioid group was induced with sufentanil 0.5 ug/kg, propofol 2 mg/kg, rocuronium 0.9 mg/kg. Anesthesia is maintained with propofol 5 mg/ kg/h and remifentanil 0.1 ug/kg/min.
Eligibility Criteria
Inclusion Criteria
1. ASA physical status I-II
2. age 18-70 years
3. thoracoscopic segmentectomy or lobectomy is proposed under general anesthesia due to pulmonary nodule
4. informed consent was obtained Exclusion Criteria
(1) body mass index ˃30 kg/m2 or ˂ 19 kg/m2 (2) preoperative use of opioids, acute and chronic pain or hyperalgesia (3) significant ischemic heart disease, including preoperative coronary artery disease, severe angina, heart failure, or structural heart disease (e.g., significant valvular disease) (4) severe hepatic and renal failure before operation (5) history of mental illness or alcoholism (6) history of alcohol or drug abuse (7) increased intracranial pressure, elevated intraocular pressure, or a diagnosis of glaucoma (8) poorly controlled or untreated hypertension (9) preeclampsia or eclampsia (10) untreated and undertreated hyperthyroidism (11) inability to complete the required rating scales
Source: ClinicalTrials.gov (NCT06310785). StuddyBuddy aggregates publicly available trial information.